APOE基因型和他类药物反应:来自英国生物库和我们所有人计划的证据
Innocent G Asiimwe1,2, Andrea L Jorgensen2, Munir Pirmohamed1
1Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
Clinical and translational science
|August 5, 2025
概括
APOE ε4基因型增加死亡风险,即使在服用他类药物的患者中也是如此. 这一发现表明,针对具有APOE ε4基因型的个体进行个性化监测或药物审查.
科学领域:
- 遗传学和心血管健康
- 药物基因组学 药物基因组学
- 流行病学 流行病学
背景情况:
- 阿波利波蛋白E (APOE) 基因型影响脂质代谢和心血管疾病风险.
- 类他类药物被广泛处方用于管理高脂血症和减少心血管事件.
- APOE基因型与他类药物反应之间的相互作用需要进一步调查.
研究的目的:
- 调查APOE基因型,他类药物使用和健康结果之间的关联.
- 分析APOE基因型对全因死亡率,心血管死亡率和主要心血管不良事件 (MACE) 的影响.
- 根据APOE基因型探索对他类药物的潜在差异反应.
主要方法:
- 利用来自英国生物银行 (UKB) 和我们所有人 (AoU) 的大规模数据集.
- 采用多变量回归和考克斯的比例危险模型.
- 使用基线数据,链接死亡记录和电子健康记录 (EHR) 评估了与脂质生物标志物,死亡率和MACE的关联.
主要成果:
- APOE ε4 载体 (ε3ε4 和 ε4ε4) 在UKB中显示出所有原因的死亡风险增加.
- APOE ε4ε4 载体在 AoU 中显示出全因死亡率升高,在 UKB 中显示出心血管死亡率升高.
- 没有发现他类药物使用和APOE基因型之间的统计学显著相互作用;然而,AoU中的脂质变化与死亡率降低有关.
结论:
- APOE ε4基因型独立地与死亡风险增加有关,不论他类药物治疗.
- 这些发现支持使用APOE基因型来识别可能受益于更密切监测或药物审查的个体.
- 进一步的研究可能会阐明特定的机制,将APOE基因型与心血管健康结果和他类药物的疗效联系起来.
更多相关视频
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.7K
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
13.1K
相关概念视频
01:26Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
873
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
873
01:11Genome-wide Association Studies-GWAS
14.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.2K
01:21Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:12Analysis of Population Pharmacokinetic Data
385
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
385